Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Published:2015-02 Issue:2 Volume:4 Page:e976507
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Li Jiang,Chen Qiu-Yan,He Jia,Li Ze-Lei,Tang Xiao-Feng,Chen Shi-Ping,Xie Chuan-Miao,Li Yong-Qiang,Huang Li-Xi,Ye Shu-bio,Ke Miao-La,Tang Lin-Quan,Liu Huai,Zhang Lu,Guo Shan-Shan,Xia Jian-Chuan,Zhang Xiao-Shi,Zheng Li-Min,Guo Xiang,Qian Chao-Nan,Mai Hai-Qiang,Zeng Yi-Xin

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/23723556.2014.976507

Reference48 articles.

1. Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy

2. The prevalence and prevention of nasopharyngeal carcinoma in China

3. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma

4. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis

5. Combined Chemoradiation Versus Radiation Therapy Alone in Locally Advanced Nasopharyngeal Carcinoma

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

2. Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics;Viruses;2024-04-25

3. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes;Molecular Cancer;2024-01-22

4. Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma;Pathology - Research and Practice;2024-01

5. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2023-09